
ã«ããã®å»åž«ããCOVIDãžã£ããšå»åž«ã®æ»äº¡ãšã®é¢é£ã«ã€ããŠãæ²é»ãå®ããªãããšããååã«èŠè«
å èšäºã¯ãã¡ã/Original article here
(ã©ã€ããµã€ããã¥ãŒãºïŒ-ã¢ã«ããŒã¿å·åšäœã®å»åž«ã§çç ç©¶è ã®ãŠã£ãªã¢ã ã»ããã¹æ°ã¯ãã«ããå»åž«äŒïŒCMAïŒã«å®ãŠã9æã®æçŽã®äžã§ããäžæ³ã«çŸ©åä»ããããCOVID-19ã¯ã¯ãã³ããšãã®çããããç¡æ°ã®ã«ããã®å»åž«ã®çªç¶ã®äžå¯©æ»ã«é¢ããŠãæ²é»ããŠããŠã¯ãããªãããšè¿°ã¹ãã
ããã¹ã¯ã"éæ³ã«çŸ©åä»ããããCOVID-19ã¯ã¯ãã³ã¯ãäœå人ãã®ã«ããã®è¥ãå»åž«ã殺ããäœå人ãã®å»åž«ãéå·ãšæ»ã®å±éºã«ããããŠãããããããªã "ãšæžããŠããã
"ç§ã¯ãããªãæ¹ã®å«çãšå®£èªãæãåºãããåŒ·ãæ±ããŠããŸãã"ãšä»ãå ããŸããã
CMAäŒé·ã®ã¢ãªã«ã»ã©ãã©ã³ããŒãå士ãšãã£ãµãªã³ã»ã¹ããŒãå士ã«éããããã®æçŽã¯ãCMAã«å¯Ÿããå»çåŸäºè ã«å¯ŸããCOVIDã¯ã¯ãã³ã®çŸ©åä»ãããã¹ãŠäžæ¢ããããšãèŠæ±ããŠããŸãã
圌ã¯ããŸã ãå®éšçããªãã®äºé²æ¥çš®ããããã«ãç©æ¥µçãã€éå«ççãã«æšé²ãããŠããããææããŸããã
ãCMAã¯ãŸããè æããä¿å¥å®åã«ãã£ãŠã«ããã®92,000人ã®å»åž«ã«åŒ·å¶ãããéæ³ãã€éç§åŠçãªCOVID-19ã¯ã¯ãã³ã®çŸ©åä»ããæ¯æããããšããã¹ã¯æžããŠããã
ãCMAã¯ãCMAã®å«çèŠå®ã«éåããŠãããè¡ããããªãæ¹2人ã¯ããããã®å«çéåã«åå ãããããªãæ¹ã¯å»åž«äŒå¡ã ãã§ãªããCMAãå¥ä»ããã«ããåœæ°ãè£åã£ãã®ã§ããããã¯CMAã®155å¹Žã®æŽå²ã®äžã§å代æªèã®ããšã§ãã"
ããã¹ã¯ãæè¿ã®ãœãŒã·ã£ã«ã¡ãã£ã¢ã®æçš¿ã§ã圌ããéå»16ã¶æã®éã«COVID-19ã®å®å šæ¥çš®äžã«æ¥æ»ããããšè¿°ã¹ã32人ã®ã«ããã®è¥ãå»åž«ã®æ»ã远跡ããŠãããšè¿°ã¹ãã
ããããã®å»åž«ã¯ãéæ³ã«çŸ©åä»ããããCOVID-19ã¯ã¯ãã³ïŒ2åã3åã4åæ¥çš®ïŒãåããåã¯ã掻çºã«å»ç掻åãããŠãããå¥åº·ã ã£ãããšããã¹ã¯æžããŠããã
ãç§ã¯ã«ããå»åž«äŒïŒCMAïŒäŒé·ã®ã¢ãªã«ã»ã©ãã©ã³ããŒãå士ãšãã£ãµãªã³ã»ã¹ããŒãåå£«ã«æçŽãéããŸããããäž¡è ãšãã«ããã®9äž2000人ã®å»åž«å šå¡ã«å¯ŸããCOVID-19ã¯ã¯ãã³ã®çŸ©åä»ããæ¯æããŠããŸãããCMAã¯ãã®å€§æšäºãç¡èŠãç¶ããããšã¯ã§ããªããã
LafontaineãšSmartã®äž¡æ°ã¯ãå®éšçãªCOVIDã®æ³šå°ãæ¿èªããããšãå ¬èšããŠãããLafontaineã¯2021幎ã«ãã®æ³šå°ã¯å®å šã§ãããšè¿°ã¹ãŠããã
ãšãŒãããã§æè¿è¡ããã2ã€ã®å»åŠçç ç©¶ã«ãããšãã³ããæ³šå°ã®å€ãã®æå®³ãªåœ±é¿ã説æããã®ã¯è¡æ¶²ã®æå·ã§ãã
ç¹ã«è¥ãç·æ§ã¯ãã³ããã¯ã¯ãã³ã«ãã£ãŠåŒãèµ·ããããå¿èã®ççãçµéšããå¯èœæ§ãé«ããªããŸãã
å®éãæè¿ã®åæ€ããŒã¿ã§ã¯ãCOVIDãŠã€ã«ã¹ãã®ãã®ãšå¿èã®åé¡ãšã®é¢é£ã§ã¯ãªããCOVID mRNAã¯ã¯ãã³ãšå¿èã®ççãšã®éã«å¯æ¥ãªé¢é£ãããããšã瀺ãããŠããŸãã
ã«ããã®å šå·ã§ã¯ãäžææãå»çåŸäºè ã«å¯Ÿããã¯ã¯ãã³æ¥çš®ã®çŸ©ååæ¿çã宿œãããããšãããã矩ååã«å察ããå€ãã®å»åž«ãçè·åž«ãçºèšãããã®çµæãè·ã倱ã£ãããå責ãåãããããè ãããã
çªç¶ã®æ»è å¢ã«åŒ·ãçå¿µãæ±ã
CMAãžã®æžç°¡ã§ããã¹ã¯ãè¥ãå»åž«ã®çªç¶æ»ã¯ "COVID-19ã¯ã¯ãã³å·å®³ã®çãã匷ãã"ãããã®ä»¥åå¥åº·ã ã£ãå»åž«ã¯ãéåžžã®èº«äœæŽ»åäžã«çªç¶æ»ããç¡ç äžã«çªç¶æ»ããå¿èçºäœãè³åäžãç°åžžãªäºæ ã«éã£ãããçªç¶çºçããæ»ææ§ã®çãçºçããŠããããã ããšè¿°ã¹ãŠããã
"ãã¡ã€ã¶ãŒãšã¢ãã«ãã¯ããã®æ¬ é¥å»è¬åã«ã€ããŠæ³ç責任ãè² ããªããããããŸããããã«ããã®å»åž«ã«ãã®åŒ·å¶çãªäœ¿çšãå ¬ã«ä¿é²ããããšã§ãããªãæ¹ã¯å ±ã«æ³ç責任ãè² ã£ãŠãããCMAãåæ§ã§ãã"ãšä»ãå ããŠããŸãã
COVID泚å°ãæ¿èªããå°ãåã«ãã«ããé£éŠæ¿åºã¯ã«ããã®ã¯ã¯ãã³å·å®³ãµããŒãããã°ã©ã ïŒVISPïŒãåµèšããŸããã
ã«ããã¯ã2020幎åŸåã«COVID泚å°ã®äœ¿çšãæ¿èªããããŸã§ãã¯ã¯ãã³å·å®³è£åããã°ã©ã ãæããªããã»ãã®äžæ¡ãã®åœã®äžã€ã§ããã
2020幎12æãã«ããæ¿åºãã¯ã¯ãã³ã¡ãŒã«ãŒã«COVID-19ã¯ã¯ãã³é¢é£ã®å·å®³ã«é¢ãã責任ãå é€ããã·ãŒã«ããäžããåŸãVISPãéå§ãããŸããã
VISPã«ãããšã2021幎6æãã2022幎6æ1æ¥ãŸã§ã«è£åãç³è«ãã人ã¯774人ã§ããã®ãã¡654人ã "èªãããã "ãšå€æãããã
COVIDã¯ã¯ãã³ã®çŸ©ååã¯ã«ãã瀟äŒãäºåããã«ããã§äœ¿çšãæ¿èªãããæ³šå°ã¯ãåäŸãã¡ã®å€æ°ã®åŠå®çã§ãã°ãã°æ·±å»ãªå¯äœçšã«é¢é£ããŠããã
å æãããã¹ã¯ã«ããã®å»åž«ã®ãçªç¶æ»ã®å¢å ãã«èŠéã鳎ããããã®æãCOVID泚å°ã®ããã«ããã£ãšå€ãã®æ»ãæ¥ãã ããããšèŠåããã
LifeSiteNewsã¯ããããã®æ»äº¡äŸã®å€ããå ±åããŠãããå»åž«ã®å¹Žéœ¢ã¯27æ³ãã62æ³ã§ããã®å€§åã¯ç·æ§ã§ããã
ã«ããã®å€ãã®å»åž«ããCOVID泚å°ã«å察ããçºèšãããããã«ãåãæ¶ãããŠããã
å æããªã³ã¿ãªãªå·ã®ãžã§ãã»ãã·ã¹ã³å»åž«ã¯ãCOVID泚å°ã®æå®³æ§ã匷調ããã€ã³ã¿ãã¥ãŒã«çããåŸãå·ã®å»çèŠå¶åœå±ããå»åž«å èš±ã9ã«æé忢ãããããã
COVIDãžã£ãã®èšåºè©Šéšã§ã¯ãã¯ã¯ãã³ãææãäŒéãæ¢ãããšãã蚌æ ã¯äžåºŠãåŸãããŠããªããå®éãç¹ã«å»ã ãšå€åãããŠã€ã«ã¹ã®äºçš®ãèæ ®ãããšããžã£ãã¯ãã¯ãéãçç¶ãæããããšããã§ãããå©ãããããå€ãã®äººã«å®³ãäžããŠããããšã瀺ã蚌æ ãããã
ãŸããäžçä¿å¥æ©é¢ã欧å·é£åãã¢ã¡ãªã«ã®ã¯ã¯ãã³æå®³äºè±¡å ±åã·ã¹ãã ïŒVAERSïŒã®ããŒã¿ã§ã¯ãäºé²æ¥çš®ã«é¢é£ããæ°çŸäžã®è² å·ãšæ°äžäººã®æ»äº¡ãå ±åãããŠããŸããããã¯ã1990幎以éã«è¡ããããã¹ãŠã®ã¯ã¯ãã³ã®åèšãããå€ãæ°ã§ãã